These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24874284)

  • 21. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance.
    Ahmed SS; Thike AA; Iqbal J; Yong WS; Tan B; Madhukumar P; Ong KW; Ho GH; Wong CY; Tan PH
    J Clin Pathol; 2014 Mar; 67(3):243-50. PubMed ID: 24218025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
    Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
    Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
    de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
    Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study.
    Maaskant-Braat AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Roumen RM; Nolthenius-Puylaert MC; Nieuwenhuijzen GA
    Breast Cancer Res Treat; 2011 May; 127(1):195-203. PubMed ID: 20680679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast.
    Creager AJ; Geisinger KR; Perrier ND; Shen P; Shaw JA; Young PR; Case D; Levine EA
    Ann Surg; 2004 Jan; 239(1):61-6. PubMed ID: 14685101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging breast cancer by sentinel lymph node biopsy: Do patients with a single negative sentinel node (N=1) experience worse outcomes than those with multiple negative sentinel nodes (N>1)?
    Wilkerson A; Averbook B; Joseph N; Sharpe S; Li B
    Surg Oncol; 2018 Sep; 27(3):327-332. PubMed ID: 30217285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma.
    Apple SK; Moatamed NA; Finck RH; Sullivan PS
    Breast; 2010 Oct; 19(5):360-4. PubMed ID: 20347308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
    Mittendorf EA; Sahin AA; Tucker SL; Meric-Bernstam F; Yi M; Nayeemuddin KM; Babiera GV; Ross MI; Feig BW; Kuerer HM; Hunt KK
    Ann Surg Oncol; 2008 Dec; 15(12):3369-77. PubMed ID: 18815841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
    Gerber B; Heintze K; Stubert J; Dieterich M; Hartmann S; Stachs A; Reimer T
    Breast Cancer Res Treat; 2011 Aug; 128(3):613-24. PubMed ID: 21523451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
    Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer.
    Rovera F; Fachinetti A; Rausei S; Chiappa C; Lavazza M; Arlant V; Marelli M; Boni L; Dionigi G; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S73-8. PubMed ID: 24380559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification of patients with early breast cancer.
    Roy PG; Chan SM; Ng V; Smith BM; Umeh H; Courtney SP
    Clin Breast Cancer; 2014 Feb; 14(1):68-73. PubMed ID: 24252507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.